Mehta, D., Raison, C. L., Woolwine, B. J., Haroon, E., Binder, E. B., Miller, A. H., & Felger, J. C. (2013). Transcriptional Signatures Related to Glucose and Lipid Metabolism Predict Treatment Response to the Tumor Necrosis Factor Antagonist Infliximab in Patients with Treatment-Resistant Depression.
শিকাগো স্টাইলে সাইটেশনMehta, Divya, Charles L. Raison, Bobbi J. Woolwine, Ebrahim Haroon, Elisabeth B. Binder, Andrew H. Miller, এবং Jennifer C. Felger. Transcriptional Signatures Related to Glucose and Lipid Metabolism Predict Treatment Response to the Tumor Necrosis Factor Antagonist Infliximab in Patients With Treatment-Resistant Depression. 2013.
এমএলএ সাইটেশনMehta, Divya, et al. Transcriptional Signatures Related to Glucose and Lipid Metabolism Predict Treatment Response to the Tumor Necrosis Factor Antagonist Infliximab in Patients With Treatment-Resistant Depression. 2013.